Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

N

NRXP

NRX Pharmaceuticals Inc

3.07

Aug 04 • 10:47 AM ET -0.17 (-5.25%)

Healthcare Biotechnology USA Micro NASD

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI SPRO VRCA KALA

| Held by: VTI PSIL VXF IWC

Scroll to Statements

Index	-
Market Cap	128.77M
Enterprise Value	122.99M
Income	-24.54M
Sales	2.29M
Book/sh	-0.41
Cash/sh	0.16
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Dec 04, 2017

P/E	-
Forward P/E	10.12
PEG	-
P/S	56.23
P/B	-
P/C	19.19
P/FCF	-
EV/EBITDA	-
EV/Sales	53.71
Quick Ratio	0.29
Current Ratio	0.29
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-1.28
EPS next Y	0.30
EPS next Q	-0.11
EPS this Y	71.72%
EPS next Y	180.06%
EPS next 5Y	-
EPS past 3/5Y	39.52% 38.42%
Sales past 3/5Y	- -
EPS Y/Y TTM	36.33%
Sales Y/Y TTM	-
EPS Q/Q	86.84%
Sales Q/Q	-
Earnings	May 15 BMO
EPS/Sales Surpr.	-119.14% -94.50%

Insider Own	11.62%
Insider Trans	0.00%
Inst Own	15.26%
Inst Trans	-1.11%
ROA	-251.79%
ROE	-
ROIC	-
Gross Margin	37.11%
Oper. Margin	-749.67%
Profit Margin	-1070.26%
SMA20	-20.91%
SMA50	-22.45%
SMA200	10.32%
Trades

Shs Outstand	41.94M
Shs Float	37.07M
Short Float	16.72%
Short Ratio	5.14
Short Interest	6.20M
52W High	5.05 -39.27%
52W Low	1.62 89.51%
Volatility	9.92% 8.45%
ATR (14)	0.33
RSI (14)	33.15
Beta	2.18
Rel Volume	1.14
Avg Volume	1.21M
Volume	327,242

Perf Week	-13.28%
Perf Month	-22.18%
Perf Quarter	2.33%
Perf Half Y	42.79%
Perf YTD	13.28%
Perf Year	12.87%
Perf 3Y	-12.21%
Perf 5Y	-97.91%
Perf 10Y	-
Recom	1.00
Target Price	39.67
Prev Close	3.24
Price	3.07
Change	-5.25%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)